Crossmark

Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1186/s41927-022-00299-3

Published Online: 2022-11-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pisaniello, Huai Leng https://orcid.org/0000-0002-0425-1697
Whittle, Samuel L.

Lester, Susan

Menz, Fiona

Metcalf, Robert

McWilliams, Leah

Hill, Catherine L.

Proudman, Susanna
License Information

Text and Data Mining valid from 2022-11-15

Version of Record valid from 2022-11-15
More Information

Article History

Received: 1 March 2022

Accepted: 7 July 2022

First Online: 15 November 2022

Declarations

:

: The study was approved by the RAH Research Ethics Committee (Research Protocol No: 981105). All study methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all study participants.

: Not applicable.

: The authors declared having no competing interests in relation to this manuscript.

Document is current

Any future updates will be listed below